stoxline Quote Chart Rank Option Currency Glossary
Relmada Therapeutics, Inc. (RLMD)
2.56  0 (0%)    12-08 16:00
Open: 2.56
High: 2.57
Volume: 94,534
Pre. Close: 2.56
Low: 2.53
Market Cap: 77(M)
Technical analysis
2023-12-08 4:45:46 PM
Short term     
Mid term     
Targets 6-month :  3.48 1-year :  3.88
Resists First :  2.98 Second :  3.32
Pivot price 2.68
Supports First :  2.41 Second :  2
MAs MA(5) :  2.53 MA(20) :  2.74
MA(100) :  2.99 MA(250) :  3.05
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  20.9 D(3) :  17
RSI RSI(14): 37.5
52-week High :  4.84 Low :  2
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RLMD ] has closed above bottom band by 33.1%. Bollinger Bands are 1.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.57 - 2.59 2.59 - 2.6
Low: 2.5 - 2.51 2.51 - 2.53
Close: 2.54 - 2.56 2.56 - 2.59
Company Description

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Headline News

Mon, 04 Dec 2023
Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Deliver On Growth Plans? - Simply Wall St

Fri, 10 Nov 2023
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2023 Earnings Call Transcript - Yahoo Finance

Wed, 08 Nov 2023
Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results - PR Newswire

Wed, 08 Nov 2023
Relmada Therapeutics Inc (RLMD) Reports Third Quarter 2023 Financial Results - Yahoo Finance

Fri, 03 Nov 2023
Relmada Therapeutics to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on ... - Yahoo Finance

Wed, 11 Oct 2023
Relmada Therapeutics to Present New Preclinical Data on its Psilocybin Program at AASLD The Liver Meeting® 2023 - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 30 (M)
Shares Float 23 (M)
Held by Insiders 7.8 (%)
Held by Institutions 60.6 (%)
Shares Short 875 (K)
Shares Short P.Month 701 (K)
Stock Financials
EPS -3.72
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.34
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -48.8 %
Return on Equity (ttm) -83.6 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -77 (M)
Levered Free Cash Flow -39 (M)
Stock Valuations
PE Ratio -0.7
PEG Ratio 0
Price to Book value 0.76
Price to Sales 0
Price to Cash Flow -1
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android